Literature DB >> 19596386

Functional role of Alix in HIV-1 replication.

Ken Fujii1, Utpal M Munshi, Sherimay D Ablan, Dimiter G Demirov, Ferri Soheilian, Kunio Nagashima, Andrew G Stephen, Robert J Fisher, Eric O Freed.   

Abstract

Retroviral Gag proteins encode small peptide motifs known as late domains that promote the release of virions from infected cells by interacting directly with host cell factors. Three types of retroviral late domains, with core sequences P(T/S)AP, YPX(n)L, and PPPY, have been identified. HIV-1 encodes a primary P(T/S)AP-type late domain and an apparently secondary late domain sequence of the YPX(n)L type. The P(T/S)AP and YPX(n)L motifs interact with the endosomal sorting factors Tsg101 and Alix, respectively. Although biochemical and structural studies support a direct binding between HIV-1 p6 and Alix, the physiological role of Alix in HIV-1 biology remains undefined. To elucidate the function of the p6-Alix interaction in HIV-1 replication, we introduced a series of mutations in the p6 Alix binding site and evaluated the effects on virus particle production and virus replication in a range of cell types, including physiologically relevant primary T cells and macrophages. We also examined the effects of the Alix binding site mutations on virion morphogenesis and single-cycle virus infectivity. We determined that the p6-Alix interaction plays an important role in HIV-1 replication and observed a particularly severe impact of Alix binding site mutations when they were combined with mutational inactivation of the Tsg101 binding site.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19596386      PMCID: PMC2744943          DOI: 10.1016/j.virol.2009.06.016

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  52 in total

1.  Plasma membrane rafts play a critical role in HIV-1 assembly and release.

Authors:  A Ono; E O Freed
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

2.  HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress.

Authors:  J Martin-Serrano; T Zang; P D Bieniasz
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

3.  Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding.

Authors:  J E Garrus; U K von Schwedler; O W Pornillos; S G Morham; K H Zavitz; H E Wang; D A Wettstein; K M Stray; M Côté; R L Rich; D G Myszka; W I Sundquist
Journal:  Cell       Date:  2001-10-05       Impact factor: 41.582

4.  AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding.

Authors:  Bettina Strack; Arianna Calistri; Stewart Craig; Elena Popova; Heinrich G Göttlinger
Journal:  Cell       Date:  2003-09-19       Impact factor: 41.582

5.  Influence of extended mutations of the HIV-1 transframe protein p6 on Nef-dependent viral replication and infectivity in vitro.

Authors:  Andreas Leiherer; Christine Ludwig; Ralf Wagner
Journal:  Virology       Date:  2009-03-09       Impact factor: 3.616

6.  Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function.

Authors:  Dimiter G Demirov; Akira Ono; Jan M Orenstein; Eric O Freed
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

7.  The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner.

Authors:  Dimiter G Demirov; Jan M Orenstein; Eric O Freed
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

8.  Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

Authors:  Xiping Wei; Julie M Decker; Hongmei Liu; Zee Zhang; Ramin B Arani; J Michael Kilby; Michael S Saag; Xiaoyun Wu; George M Shaw; John C Kappes
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

9.  Defects in human immunodeficiency virus budding and endosomal sorting induced by TSG101 overexpression.

Authors:  Ritu Goila-Gaur; Dimiter G Demirov; Jan M Orenstein; Akira Ono; Eric O Freed
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

10.  The nucleocapsid region of HIV-1 Gag cooperates with the PTAP and LYPXnL late domains to recruit the cellular machinery necessary for viral budding.

Authors:  Vincent Dussupt; Melodi P Javid; Georges Abou-Jaoudé; Joshua A Jadwin; Jason de La Cruz; Kunio Nagashima; Fadila Bouamr
Journal:  PLoS Pathog       Date:  2009-03-13       Impact factor: 6.823

View more
  60 in total

Review 1.  Proline-rich regions and motifs in trafficking: from ESCRT interaction to viral exploitation.

Authors:  Xuefeng Ren; James H Hurley
Journal:  Traffic       Date:  2011-05-13       Impact factor: 6.215

2.  Viral infection: Moving through complex and dynamic cell-membrane structures.

Authors:  Jonathan Barroso-González; Laura García-Expósito; Julià Blanco; Agustín Valenzuela-Fernández; Isabel Puigdomènech; Laura de Armas-Rillo; José-David Machado
Journal:  Commun Integr Biol       Date:  2011-07-01

Review 3.  Dynamics of ESCRT proteins.

Authors:  Nolwenn Jouvenet
Journal:  Cell Mol Life Sci       Date:  2012-06-06       Impact factor: 9.261

Review 4.  HIV-1 assembly, budding, and maturation.

Authors:  Wesley I Sundquist; Hans-Georg Kräusslich
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

5.  Identification and structural characterization of the ALIX-binding late domains of simian immunodeficiency virus SIVmac239 and SIVagmTan-1.

Authors:  Qianting Zhai; Michael B Landesman; Howard Robinson; Wesley I Sundquist; Christopher P Hill
Journal:  J Virol       Date:  2010-10-20       Impact factor: 5.103

6.  Basic residues in the nucleocapsid domain of Gag are critical for late events of HIV-1 budding.

Authors:  Vincent Dussupt; Paola Sette; Nana F Bello; Melodi P Javid; Kunio Nagashima; Fadila Bouamr
Journal:  J Virol       Date:  2010-12-15       Impact factor: 5.103

Review 7.  A Consensus View of ESCRT-Mediated Human Immunodeficiency Virus Type 1 Abscission.

Authors:  J Lippincott-Schwartz; E O Freed; S B van Engelenburg
Journal:  Annu Rev Virol       Date:  2017-07-17       Impact factor: 10.431

8.  Identification of the HIV-1 NC binding interface in Alix Bro1 reveals a role for RNA.

Authors:  Paola Sette; Vincent Dussupt; Fadila Bouamr
Journal:  J Virol       Date:  2012-08-15       Impact factor: 5.103

Review 9.  Novel approaches to inhibiting HIV-1 replication.

Authors:  Catherine S Adamson; Eric O Freed
Journal:  Antiviral Res       Date:  2009-09-24       Impact factor: 5.970

10.  The Phe105 loop of Alix Bro1 domain plays a key role in HIV-1 release.

Authors:  Paola Sette; Ruiling Mu; Vincent Dussupt; Jiansheng Jiang; Greg Snyder; Patrick Smith; Tsan Sam Xiao; Fadila Bouamr
Journal:  Structure       Date:  2011-09-01       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.